COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Thumbnail

Testing AL and nursing homes for COVID-19 would cost $672M

Testing the combined residents of the nation’s assisted living facilities and nursing homes would cost a whopping $672 million for just one round of testing.

Q&A: Cardiologist Fatima Rodriguez on the AHA’s COVID-19 patient data registry

Back in April, the American Heart Association launched a new patient data registry to learn more about COVID-19 and its associations with cardiovascular disease. We reached out to the AHA for an update on that registry's progress. 

Thumbnail

North Dakota has the best health infrastructure during the COVID-19 pandemic

WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.

Thumbnail

‘Do-not-resuscitate’ orders for COVID-19 patients?

New findings highlight why a blanket “do-not-resuscitate” order for COVID-19 patients is not needed. 

Thumbnail

Stroke rates are low among COVID-19 patients—but when they occur, the risk of death is substantial

The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020. 

Thumbnail

Biopharma may not come out on top from COVID-19 pandemic

While emerging conventional wisdom may state biopharmaceutical companies could see a boon as a result of the COVID-19 pandemic thanks to new treatment and vaccine opportunities, the sector may not come out on top.

Thumbnail

Testing nursing homes for COVID-19 costs $440M

Testing all residents and staff at the nation’s nursing homes just once would collectively cost $440 million, according to data from the American Health Care Association and National Center of Assisted Living (AHCA/NCAL).

Thumbnail

President Trump says he is taking hydroxychloroquine to prevent COVID-19 infection

The news came just weeks after the FDA warned against treating COVID-19 with hydroxychloroquine “outside of the hospital setting or a clinical trial” due to significant cardiovascular complications.